Rubinstein Samuel purchased $7K of MDWD (indirect holdings)
Rubinstein Samuel purchased 525 indirectly-held shares of MediWound Ltd. (MDWD) at $12.62 on 2026-09-01.
How this was made
The 30-second read
Why it matters
The transaction is small relative to typical market volume and likely has negligible effect on MDWD's price.
Market read
Limited relevance; primarily of interest to investors tracking insider activity.
What to watch
Potential upcoming clinical data or regulatory events not disclosed.
Background
Form 4 filings disclose insider trades; this filing reports a director's purchase.
Ticker impact
Director Rubinstein Samuel bought 525 shares for $6,625.50 in a Form 4 filing.
Minimal price movement expected.
Purchase size is modest ($6.6k) and unlikely to move the stock significantly.
Market effects
None
None
None
Counterpoint
Insider purchase could be routine compensation rather than a strong bullish signal.
Key entities
- CompanyMediWound Ltd.
Biotech firm listed under ticker MDWD.
- InsiderRubinstein Samuel
Director of MediWound Ltd. who made the purchase.